The c.-133A > G polymorphism in NPC1L1 gene influences the efficacy of ezetimibe monotherapy on apolipoprotein A1 in hyperlipidemic patients.

Zsíros, N; Bodor, M; Varga, V; Berta, E; Balogh, I; Seres, I; Paragh, G; Harangi, M.
Pharmazie; 69(6): 424-9, 2014 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-24974575